Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |